Evidence map›Paper›PMID 30800127›Full record

ArticleFrontiers in immunology2019

Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB

Diana M Elizondo, Nailah Z D Brandy, Ricardo L L da Silva, Naomi L Haddock, Apollo D Kacsinta, Tatiana R de Moura, Michael W Lipscomb

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. CCR5 marks a subset of mouse hematopoietic stem cells that are myeloid primed and expand with age.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The immune cell atlas of human neuroblastoma.Cell reports. Medicine · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Diana M ElizondoDepartment of Biology, Howard University, Washington, DC, United States.
Nailah Z D BrandyDepartment of Biology, Howard University, Washington, DC, United States.
Ricardo L L da SilvaDepartment of Biology, Howard University, Washington, DC, United States.
Naomi L HaddockDepartment of Biology, Howard University, Washington, DC, United States.
Apollo D KacsintaDepartment of Cellular and Molecular Medicine, UCSD School of Medicine, La Jolla, CA, United States.
Tatiana R de MouraLaboratório de Imunologia e Biologia Molecular-Hospital Universitário, Universidade Federal de Sergipe, Aracaju, Brazil.
Michael W LipscombDepartment of Biology, Howard University, Washington, DC, United States.
Howard University · USStanford University · USUniversidade Federal de Sergipe · BRUniversity of California, San Diego · US

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Development of tolerogenic dendritic cell-based immunotherapies and restorative insulin approaches to alleviate type 1 diabetesSC1GM127207 · NIGMS · HOWARD UNIVERSITY · PI LIPSCOMB, MICHAEL W · 2018 to 2021
$1.5M
Crosstalk and the cytoskeleton in dendritic cell antigen presentationSC2GM103741 · NIGMS · HOWARD UNIVERSITY · PI LIPSCOMB, MICHAEL W · 2015 to 2017
$441k
NIGMS NIH HHS K12 GM068524NIGMS NIH HHS SC1 GM127207
6 · The paper itself

Abstract

The multistep differentiation process from hematopoietic stem cells through common myeloid progenitors into committed dendritic cell (DC) subsets remains to be fully addressed. These studies now show that Allograft Inflammatory Factor-1 (AIF1) is required for differentiation of classical DC type 1 (cDC1) subsets and monocyte-derived DC (Mo-DC). Phenotypic studies found that AIF1 expression increased in committed subsets differentiating from common myeloid progenitors (CMP). However, silencing AIF1 expression in hematopoietic stem progenitors restrained the capacity to differentiate into Mo-DC and cDC1 cell subsets under GM-CSF or Flt3-L stimuli conditions, respectively. This was further marked by restrained expression of IRF8, which is critical for development of Mo-DC and cDC1 subsets. As a result, absence of AIF1 restrained the cells at the Lin

Indexed as

AnimalsBone Marrow CellsCalcium-Binding ProteinsCell DifferentiationCells, CulturedDendritic CellsFemaleGene Knockdown TechniquesGranulocyte-Macrophage Colony-Stimulating FactorHematopoiesisHematopoietic Stem CellsInterferon Regulatory Factor-8Interferon Regulatory FactorsMaleMembrane ProteinsMiceAif1 protein, mouseCalcium-Binding Proteinsflt3 ligand proteinGranulocyte-Macrophage Colony-Stimulating FactorInterferon Regulatory Factor-8Interferon Regulatory FactorsMembrane ProteinsMicrofilament ProteinsNF-kappa B p50 SubunitNfkb1 protein, mousep38 Mitogen-Activated Protein KinasesProtein Kinase CRelb protein, mouseRNA, Small InterferingTranscription Factor RelBallograft inflammatory factor 1cDC1 dendritic cellsdendritic cellshematopoietic stem cellsIRF8 transcriptional coactivatormonocyte-derived DCprotein kinase C (PKC)RelB/NFκB

Identifiers

PMID30800127
PMCPMC6375893
OpenAlexW2911944218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.